1,620 research outputs found
Rydberg-London Potential for Diatomic Molecules and Unbonded Atom Pairs
We propose and test a pair potential that is accurate at all relevant
distances and simple enough for use in large-scale computer simulations. A
combination of the Rydberg potential from spectroscopy and the London
inverse-sixth-power energy, the proposed form fits spectroscopically determined
potentials better than the Morse, Varnshi, and Hulburt-Hirschfelder potentials
and much better than the Lennard-Jones and harmonic potentials. At long
distances, it goes smoothly to the correct London force appropriate for gases
and preserves van der Waals's "continuity of the gas and liquid states," which
is routinely violated by coefficients assigned to the Lennard-Jones 6-12 form.Comment: Five pages, 10 figure
A simple approach to the correlation of rotovibrational states in four-atomic molecules
The problem of correlation between quantum states of four-atomic molecules in
different geometrical configurations is reviewed in detail. A general, still
simple rule is obtained which allows one to correlate states of a linear
four-atomic molecule with those of any kind of non-linear four-atomic molecule.Comment: 16 pages (+8 figures), Postscript (ready to print!
Perioperative antithrombotic (antiplatelet and anticoagulant) therapy in urological practice : A critical assessment and summary of the Clinical Practice Guidelines
Peer reviewedPostprin
Vena cava inferior thrombosis detected by venous hum: a case report
We describe a patient in which a venous hum, heard during abdominal auscultation, lead to the diagnosis of a vena cava inferior thrombosis
Perioperative Anticoagulation in Patients with Mechanical Heart Valves Undergoing Elective Surgery: Results of a Survey Conducted among Korean Physicians
The optimal perioperative anticoagulation management in patients on warfarin therapy is poorly defined due to the lack of randomized trials. Because guidelines are heterogeneous, it was hypothesized that "treatment strategies are not uniform in clinical practice". Between February 2003 and May 2003, a questionnaire with 4 different clinical scenarios was distributed to physicians by e-mail, or direct contact was made by a survey monitor. Two scenarios described the cases of patients with a mechanical heart valve (MHV) in the mitral position, with additional risk factors for a systemic embolism; one undergoing major (scenario 1) and the other minor surgery (scenario 3). Two scenarios described patients with an aortic MHV; one undergoing major (scenario 2) and the other minor (scenario 4) surgery. Different preoperative and postoperative management options were offered. The treatment options for all scenarios were the same. Of the 90 questionnaires distributed, 52 (57.8%) were returned. Hospitalization for full-dose intravenous unfractionated heparin (IV UH) was the most commonly selected strategy in the preoperative phase for scenarios 1 (59%), 2 (42%) and 3 (44%). In scenario 4, 34% chose IV UH. Outpatient, full-dose, subcutaneous UH or low-molecular-weight heparin (LMWH) was the most selected option in the postoperative phase for all scenarios, with the exception of number 4 (52.9% in scenario 1, 34% in scenario 2, 32%, in scenario 3 and 28% in scenario 4). Even among expert clinicians, the management of perioperative anticoagulation is heterogeneous. In particular, the definition of risk categories and the optimal intensity of antithrombotic drugs need to be defined by well-designed prospective studies
Slow fluctuations in enhanced Raman scattering and surface roughness relaxation
We propose an explanation for the recently measured slow fluctuations and
``blinking'' in the surface enhanced Raman scattering (SERS) spectrum of single
molecules adsorbed on a silver colloidal particle. We suggest that these
fluctuations may be related to the dynamic relaxation of the surface roughness
on the nanometer scale and show that there are two classes of roughness with
qualitatively different dynamics. The predictions agree with measurements of
surface roughness relaxation. Using a theoretical model for the kinetics of
surface roughness relaxation in the presence of charges and optical electrical
fields, we predict that the high-frequency electromagnetic field increases both
the effective surface tension and the surface diffusion constant and thus
accelerates the surface smoothing kinetics and time scale of the Raman
fluctuations in manner that is linear with the laser power intensity, while the
addition of salt retards the surface relaxation kinetics and increases the time
scale of the fluctuations. These predictions are in qualitative agreement with
the Raman experiments
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
BACKGROUND: It is uncertain whether bridging anticoagulation is necessary for patients with atrial fibrillation who need an interruption in warfarin treatment for an elective operation or other elective invasive procedure. We hypothesized that forgoing bridging anticoagulation would be noninferior to bridging with low-molecular-weight heparin for the prevention of perioperative arterial thromboembolism and would be superior to bridging with respect to major bleeding. METHODS: We performed a randomized, double-blind, placebo-controlled trial in which, after perioperative interruption of warfarin therapy, patients were randomly assigned to receive bridging anticoagulation therapy with low-molecular-weight heparin (100 IU of dalteparin per kilogram of body weight) or matching placebo administered subcutaneously twice daily, from 3 days before the procedure until 24 hours before the procedure and then for 5 to 10 days after the procedure. Warfarin treatment was stopped 5 days before the procedure and was resumed within 24 hours after the procedure. Follow-up of patients continued for 30 days after the procedure. The primary outcomes were arterial thromboembolism (stroke, systemic embolism, or transient ischemic attack) and major bleeding. RESULTS: In total, 1884 patients were enrolled, with 950 assigned to receive no bridging therapy and 934 assigned to receive bridging therapy. The incidence of arterial thromboembolism was 0.4% in the no-bridging group and 0.3% in the bridging group (risk difference, 0.1 percentage points; 95% confidence interval [CI], -0.6 to 0.8; P=0.01 for noninferiority). The incidence of major bleeding was 1.3% in the no-bridging group and 3.2% in the bridging group (relative risk, 0.41; 95% CI, 0.20 to 0.78; P=0.005 for superiority). CONCLUSIONS: In patients with atrial fibrillation who had warfarin treatment interrupted for an elective operation or other elective invasive procedure, forgoing bridging anticoagulation was noninferior to perioperative bridging with low-molecular-weight heparin for the prevention of arterial thromboembolism and decreased the risk of major bleeding. (Funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health; BRIDGE ClinicalTrials.gov number, NCT00786474.)
Guidance for the evaluation and treatment of hereditary and acquired thrombophilia
Thrombophilias are hereditary and/or acquired conditions that predispose patients to thrombosis. Testing for thrombophilia is commonly performed in patients with venous thrombosis and their relatives; however such testing usually does not provide information that impacts management and may result in harm. This manuscript, initiated by the Anticoagulation Forum, provides clinical guidance for thrombophilia testing in five clinical situations: following 1) provoked venous thromboembolism, 2) unprovoked venous thromboembolism; 3) in relatives of patients with thrombosis, 4) in female relatives of patients with thrombosis considering estrogen use; and 5) in female relatives of patients with thrombosis who are considering pregnancy. Additionally, guidance is provided regarding the timing of thrombophilia testing. The role of thrombophilia testing in arterial thrombosis and for evaluation of recurrent pregnancy loss is not addressed. Statements are based on existing guidelines and consensus expert opinion where guidelines are lacking. We recommend that thrombophilia testing not be performed in most situations. When performed, it should be used in a highly selective manner, and only in circumstances where the information obtained will influence a decision important to the patient, and outweigh the potential risks of testing. Testing should not be performed during acute thrombosis or during the initial (3-month) period of anticoagulation
Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis
Objective To determine the effect of sex on the risk of recurrent venous thromboembolism in all patients and in patients with venous thromboembolism that was unprovoked or provoked (by non-hormonal factors)
- ā¦